Logo image of SBH

SALLY BEAUTY HOLDINGS INC (SBH) Stock Fundamental Analysis

USA - NYSE:SBH - US79546E1047 - Common Stock

15 USD
+0.03 (+0.2%)
Last: 10/21/2025, 7:00:00 PM
15 USD
0 (0%)
After Hours: 10/21/2025, 7:00:00 PM
Fundamental Rating

5

SBH gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 119 industry peers in the Specialty Retail industry. SBH has an average financial health and profitability rating. SBH may be a bit undervalued, certainly considering the very reasonable score on growth This makes SBH very considerable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year SBH was profitable.
SBH had a positive operating cash flow in the past year.
In the past 5 years SBH has always been profitable.
SBH had a positive operating cash flow in each of the past 5 years.
SBH Yearly Net Income VS EBIT VS OCF VS FCFSBH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

1.2 Ratios

With a decent Return On Assets value of 7.07%, SBH is doing good in the industry, outperforming 78.99% of the companies in the same industry.
The Return On Equity of SBH (25.43%) is better than 82.35% of its industry peers.
SBH has a Return On Invested Capital of 11.02%. This is in the better half of the industry: SBH outperforms 75.63% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SBH is in line with the industry average of 12.29%.
Industry RankSector Rank
ROA 7.07%
ROE 25.43%
ROIC 11.02%
ROA(3y)6.46%
ROA(5y)6.35%
ROE(3y)41.08%
ROE(5y)188.75%
ROIC(3y)11.72%
ROIC(5y)11.63%
SBH Yearly ROA, ROE, ROICSBH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 600

1.3 Margins

SBH has a better Profit Margin (5.26%) than 76.47% of its industry peers.
In the last couple of years the Profit Margin of SBH has declined.
SBH has a better Operating Margin (8.99%) than 79.83% of its industry peers.
SBH's Operating Margin has declined in the last couple of years.
SBH has a better Gross Margin (51.39%) than 79.83% of its industry peers.
SBH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.99%
PM (TTM) 5.26%
GM 51.39%
OM growth 3Y-11.35%
OM growth 5Y-8.43%
PM growth 3Y-12.64%
PM growth 5Y-10.04%
GM growth 3Y0.3%
GM growth 5Y0.63%
SBH Yearly Profit, Operating, Gross MarginsSBH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

5

2. Health

2.1 Basic Checks

SBH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, SBH has less shares outstanding
Compared to 5 years ago, SBH has less shares outstanding
The debt/assets ratio for SBH has been reduced compared to a year ago.
SBH Yearly Shares OutstandingSBH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
SBH Yearly Total Debt VS Total AssetsSBH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.95 indicates that SBH is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.95, SBH is in the better half of the industry, outperforming 66.39% of the companies in the same industry.
SBH has a debt to FCF ratio of 5.28. This is a neutral value as SBH would need 5.28 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 5.28, SBH is doing good in the industry, outperforming 62.18% of the companies in the same industry.
SBH has a Debt/Equity ratio of 1.16. This is a high value indicating a heavy dependency on external financing.
SBH has a Debt to Equity ratio of 1.16. This is in the lower half of the industry: SBH underperforms 60.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF 5.28
Altman-Z 2.95
ROIC/WACC1.13
WACC9.75%
SBH Yearly LT Debt VS Equity VS FCFSBH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 2.41 indicates that SBH has no problem at all paying its short term obligations.
SBH has a Current ratio of 2.41. This is amongst the best in the industry. SBH outperforms 84.87% of its industry peers.
SBH has a Quick Ratio of 2.41. This is a bad value and indicates that SBH is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.49, SBH perfoms like the industry average, outperforming 47.06% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.41
Quick Ratio 0.49
SBH Yearly Current Assets VS Current LiabilitesSBH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

4

3. Growth

3.1 Past

SBH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.81%, which is quite good.
SBH shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.65% yearly.
SBH shows a decrease in Revenue. In the last year, the revenue decreased by -0.38%.
Measured over the past years, SBH shows a decrease in Revenue. The Revenue has been decreasing by -0.84% on average per year.
EPS 1Y (TTM)14.81%
EPS 3Y-10.79%
EPS 5Y-5.65%
EPS Q2Q%13.33%
Revenue 1Y (TTM)-0.38%
Revenue growth 3Y-1.38%
Revenue growth 5Y-0.84%
Sales Q2Q%-0.96%

3.2 Future

The Earnings Per Share is expected to grow by 9.03% on average over the next years. This is quite good.
SBH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.72% yearly.
EPS Next Y9.22%
EPS Next 2Y9.57%
EPS Next 3Y9.03%
EPS Next 5YN/A
Revenue Next Year-0.85%
Revenue Next 2Y0.23%
Revenue Next 3Y0.72%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SBH Yearly Revenue VS EstimatesSBH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
SBH Yearly EPS VS EstimatesSBH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.06 indicates a reasonable valuation of SBH.
Compared to the rest of the industry, the Price/Earnings ratio of SBH indicates a rather cheap valuation: SBH is cheaper than 92.44% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.77, SBH is valued rather cheaply.
The Price/Forward Earnings ratio is 7.39, which indicates a rather cheap valuation of SBH.
92.44% of the companies in the same industry are more expensive than SBH, based on the Price/Forward Earnings ratio.
SBH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.23.
Industry RankSector Rank
PE 8.06
Fwd PE 7.39
SBH Price Earnings VS Forward Price EarningsSBH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SBH indicates a rather cheap valuation: SBH is cheaper than 85.71% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SBH indicates a rather cheap valuation: SBH is cheaper than 89.92% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.83
EV/EBITDA 5.2
SBH Per share dataSBH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SBH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.87
PEG (5Y)N/A
EPS Next 2Y9.57%
EPS Next 3Y9.03%

0

5. Dividend

5.1 Amount

SBH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SALLY BEAUTY HOLDINGS INC

NYSE:SBH (10/21/2025, 7:00:00 PM)

After market: 15 0 (0%)

15

+0.03 (+0.2%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-06 2025-11-06/amc
Inst Owners120.1%
Inst Owner Change-0.14%
Ins Owners0.89%
Ins Owner Change0.49%
Market Cap1.48B
Analysts71.11
Price Target14.74 (-1.73%)
Short Float %20.19%
Short Ratio8.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.63%
Min EPS beat(2)6.17%
Max EPS beat(2)19.09%
EPS beat(4)3
Avg EPS beat(4)7.09%
Min EPS beat(4)-1.32%
Max EPS beat(4)19.09%
EPS beat(8)5
Avg EPS beat(8)3.09%
EPS beat(12)8
Avg EPS beat(12)3.36%
EPS beat(16)10
Avg EPS beat(16)3.2%
Revenue beat(2)0
Avg Revenue beat(2)-1.75%
Min Revenue beat(2)-3%
Max Revenue beat(2)-0.51%
Revenue beat(4)0
Avg Revenue beat(4)-1.55%
Min Revenue beat(4)-3%
Max Revenue beat(4)-0.51%
Revenue beat(8)1
Avg Revenue beat(8)-1.26%
Revenue beat(12)4
Avg Revenue beat(12)-0.55%
Revenue beat(16)6
Avg Revenue beat(16)-0.84%
PT rev (1m)7.43%
PT rev (3m)20.42%
EPS NQ rev (1m)4.93%
EPS NQ rev (3m)7.34%
EPS NY rev (1m)0%
EPS NY rev (3m)5.15%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.91%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.16%
Valuation
Industry RankSector Rank
PE 8.06
Fwd PE 7.39
P/S 0.4
P/FCF 8.83
P/OCF 5.61
P/B 1.95
P/tB 8.95
EV/EBITDA 5.2
EPS(TTM)1.86
EY12.4%
EPS(NY)2.03
Fwd EY13.53%
FCF(TTM)1.7
FCFY11.32%
OCF(TTM)2.67
OCFY17.83%
SpS37.29
BVpS7.71
TBVpS1.68
PEG (NY)0.87
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.07%
ROE 25.43%
ROCE 14.93%
ROIC 11.02%
ROICexc 11.61%
ROICexgc 16.2%
OM 8.99%
PM (TTM) 5.26%
GM 51.39%
FCFM 4.55%
ROA(3y)6.46%
ROA(5y)6.35%
ROE(3y)41.08%
ROE(5y)188.75%
ROIC(3y)11.72%
ROIC(5y)11.63%
ROICexc(3y)12.3%
ROICexc(5y)13.11%
ROICexgc(3y)17.54%
ROICexgc(5y)19.12%
ROCE(3y)15.88%
ROCE(5y)15.76%
ROICexcg growth 3Y-19.08%
ROICexcg growth 5Y-16.57%
ROICexc growth 3Y-17.14%
ROICexc growth 5Y-14.25%
OM growth 3Y-11.35%
OM growth 5Y-8.43%
PM growth 3Y-12.64%
PM growth 5Y-10.04%
GM growth 3Y0.3%
GM growth 5Y0.63%
F-Score8
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF 5.28
Debt/EBITDA 2.04
Cap/Depr 94.92%
Cap/Sales 2.62%
Interest Coverage 4.81
Cash Conversion 61.07%
Profit Quality 86.6%
Current Ratio 2.41
Quick Ratio 0.49
Altman-Z 2.95
F-Score8
WACC9.75%
ROIC/WACC1.13
Cap/Depr(3y)93.39%
Cap/Depr(5y)91.26%
Cap/Sales(3y)2.59%
Cap/Sales(5y)2.56%
Profit Quality(3y)70.61%
Profit Quality(5y)123.87%
High Growth Momentum
Growth
EPS 1Y (TTM)14.81%
EPS 3Y-10.79%
EPS 5Y-5.65%
EPS Q2Q%13.33%
EPS Next Y9.22%
EPS Next 2Y9.57%
EPS Next 3Y9.03%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.38%
Revenue growth 3Y-1.38%
Revenue growth 5Y-0.84%
Sales Q2Q%-0.96%
Revenue Next Year-0.85%
Revenue Next 2Y0.23%
Revenue Next 3Y0.72%
Revenue Next 5YN/A
EBIT growth 1Y19.75%
EBIT growth 3Y-12.57%
EBIT growth 5Y-9.19%
EBIT Next Year40.08%
EBIT Next 3Y14.46%
EBIT Next 5YN/A
FCF growth 1Y16.5%
FCF growth 3Y-22.14%
FCF growth 5Y-7.32%
OCF growth 1Y10.21%
OCF growth 3Y-13.58%
OCF growth 5Y-5.11%